Last updated on November 2017

A Phase 2, Multicenter, Randomized, Parallel-arm, Placebo-Controlled Study of LY3074828 in Subjects with Active Crohn’s Disease


Brief description of study

A Phase 2, Multicenter, Randomized, Parallel-arm, Placebo-Controlled Study of LY3074828 in Subjects with Active Crohn’s Disease

Detailed Study Description

All subjects in the study will have had loss of response or intolerance to conventional medication used to treat Crohn’s disease.

Clinical Study Identifier: TX10830

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Research Center

Columbus Regional Research Institute
Columbus, GA USA
  Connect »